These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1708044)

  • 1. Mode of action of a new class IC drug (ORG 7797) against atrial fibrillation in conscious dogs.
    Kirchhof C; Wijffels M; Brugada J; Planellas J; Allessie M
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):116-24. PubMed ID: 1708044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flecainide on the rate dependence of atrial refractoriness, atrial repolarization and atrioventricular node conduction in anesthetized dogs.
    O'Hara G; Villemaire C; Talajic M; Nattel S
    J Am Coll Cardiol; 1992 May; 19(6):1335-42. PubMed ID: 1564235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravenous anesthetics on atrial wavelength and atrioventricular nodal conduction in guinea pig heart. Potential antidysrhythmic properties and clinical implications.
    Napolitano CA; Raatikainen MJ; Martens JR; Dennis DM
    Anesthesiology; 1996 Aug; 85(2):393-402. PubMed ID: 8712456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation.
    Wang Z; Pagé P; Nattel S
    Circ Res; 1992 Aug; 71(2):271-87. PubMed ID: 1628386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electropharmacologic effects of pilsicainide, a pure sodium channel blocker, on the remodeled atrium subjected to chronic rapid pacing.
    Sato T; Mitamura H; Kurita Y; Takeshita A; Shinagawa K; Miyoshi S; Kanki H; Hara M; Ogawa S
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):812-20. PubMed ID: 11707684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
    Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation.
    Feld GK; Cha Y
    J Cardiovasc Pharmacol Ther; 1997 Jul; 2(3):195-203. PubMed ID: 10684458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent.
    Kambayashi R; Hagiwara-Nagasawa M; Ichikawa T; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Takahara A; Sugiyama A
    Heart Vessels; 2020 Sep; 35(9):1316-1322. PubMed ID: 32346771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation.
    Burashnikov A; Di Diego JM; Sicouri S; Ferreiro M; Carlsson L; Antzelevitch C
    Heart Rhythm; 2008 Dec; 5(12):1735-42. PubMed ID: 19084813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of E047/1, a new antiarrhythmic drug, on experimental atrial fibrillation in anesthetized dogs.
    Sharifov OF; Fedorov VV; Beloshapko GG; Yushmanova AV; Rosenshtraukh LV
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):706-14. PubMed ID: 11602817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.
    Li Y; Li W; Yang B; Han W; Dong D; Xue J; Li B; Yang S; Sheng L
    J Electrocardiol; 2007 Jan; 40(1):100.e1-6. PubMed ID: 17067622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics.
    Kanki H; Mitamura H; Takatsuki S; Sueyoshi K; Shinagawa K; Sato T; Ogawa S
    Cardiovasc Drugs Ther; 1998 Oct; 12(5):475-82. PubMed ID: 9926279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.
    Yamamoto W; Hashimoto N; Matsuura J; Machida T; Ogino Y; Kobayashi T; Yamanaka Y; Ishiwata N; Yamashita T; Tanimoto K; Miyoshi S; Fukuda K; Nakaya H; Ogawa S
    J Cardiovasc Pharmacol; 2014 May; 63(5):421-7. PubMed ID: 24805146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing effects of spontaneous and atropine-induced variations of vagal tone on atrial refractoriness in the conscious dog.
    Boucher M; Dubray C; Duchene-Marullaz P
    Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):397-401. PubMed ID: 3762264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs.
    Laurent G; Leong-Poi H; Mangat I; Moe GW; Hu X; So PP; Tarulli E; Ramadeen A; Rossman EI; Hennan JK; Dorian P
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):171-8. PubMed ID: 19808462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of SD-3212, a new class I antiarrhythmic drug, on canine atrial flutter and atrial action-potential characteristics.
    Fujiki A; Tani M; Hayashi H; Mizumaki K; Inoue H; Uemura H; Nakaya H
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):471-5. PubMed ID: 9156356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist.
    Patterson E; Scherlag BJ; Zhou J; Jackman WM; Lazzara R; Coscia D; Po S
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):861-8. PubMed ID: 18363689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.